Zobrazeno 1 - 9 of 9 pro vyhledávání: '"James C. Gahn"'
1
Budget Impact Analysis of Vibegron for the Treatment of Overactive Bladder in the USA
Autor: Jing Voon Chen, James C. Gahn, Jeffrey Nesheim, Paul N. Mudd
Publikováno v: PharmacoEconomics. 40(10)
Overactive bladder (OAB) is associated with considerable clinical and economic burden. Treatment of patients with OAB using anticholinergics is limited by tolerability issues and increased anticholinergic burden, which is associated with increased ri
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::326e827f6fcaf53e5a1862ce19a9c2df
https://pubmed.ncbi.nlm.nih.gov/35881325
Zobrazit plný text záznamu
2
Computer Modeling of Diabetes and Its Transparency
Autor: Penny Breeze, Jose Leal, Andrew J. Palmer, Lei Si, Talitha L Feenstra, Alan Brennan, Alastair Gray, Michelle Tew, William J. Valentine, William H. Herman, Mark Lamotte, Volker Foos, James C. Gahn, Christian Asseburg, Harry J. Smolen, Xinyang Hua, Michael Brändle, Patrick J. O'Connor, Shihchen Kuo, Wen Ye, Philip Christopher McEwan, Daniel Pollard, An Tran-Duy, Michael Willis, Neda Laiteerapong, Deanna J. M. Isaman, Philip Clarke, Richard F Pollock
Publikováno v: Value in Health, 21(6), 724-731. ELSEVIER SCIENCE INC
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Objectives\ud The Eighth Mount Hood Challenge (held in St. Gallen, Switzerland, in September 2016) evaluated the transparency of model input documentation from two published health economics studies and developed guidelines for improving transparency
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c141f98bf83253c299219eed0b0287d6
https://hdl.handle.net/11370/bd3df083-24c6-43a5-8807-43c5253a8a18
Zobrazit plný text záznamu
3
The Evaluation of Clinical and Cost Outcomes Associated with Earlier Initiation of Insulin in Patients with Type 2 Diabetes Mellitus
Autor: Daniel R Murphy, Bradley H. Curtis, Xueting Yu, Harry J. Smolen, James C. Gahn
Publikováno v: Journal of Managed Care Pharmacy. 20:968-984
The treatment for patients with type 2 diabetes mellitus (T2DM) follows a stepwise progression. As a treatment loses its effectiveness, it is typically replaced with a more complex and frequently more costly treatment. Eventually this progression lea
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9f4410edd3c2912ee6d38ace333dc9e
https://doi.org/10.18553/jmcp.2014.20.9.968
Zobrazit plný text záznamu
4
Evaluation of a patient self-directed mealtime insulin titration algorithm: a US payer perspective
Autor: James F. Murray, James C Gahn, Bradley H. Curtis, Leonard C. Glass, Sarah E Curtis, Sinem Perk, Daniel R Murphy, Rong Liu, Nana Numapau, Jeffrey S. Bonner, Harry J. Smolen, Jennal Johnson
Publikováno v: Journal of medical economics. 19(6)
Objective: To model the potential economic impact of implementing the AUTONOMY once daily (Q1D) patient self-titration mealtime insulin dosing algorithm versus standard of care (SOC) among a population of patients with Type 2 diabetes living in the U
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d2e121352735ca8f0790852d29464c1
https://pubmed.ncbi.nlm.nih.gov/26756804
Zobrazit plný text záznamu
5
Febuxostat in the management of gout: a cost-effectiveness analysis
Autor: James C Gahn, Aki Shiozawa, Lee J Smolen, Ghaith Mitri
Publikováno v: Journal of medical economics. 19(3)
To determine the cost-effectiveness of febuxostat vs allopurinol for the management of gout.A stochastic microsimulation cost-effectiveness model with a US private-payer perspective and 5-year time horizon was developed. Model flow based on guideline
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1f692213b5dfd17c8c74a1917e33846
https://pubmed.ncbi.nlm.nih.gov/26535593
Zobrazit plný text záznamu
6
The Budget Impact of Increased Use of Febuxostat in the Management of Gout: A US Health Plan Managed Care Pharmacy and Medical Costs Perspective
Autor: Lee J Smolen, Aki Shiozawa, Ghaith Mitri, James C Gahn
Publikováno v: Clinical therapeutics. 38(7)
Gout is a chronic disease characterized by the deposition of urate crystals in the joints and throughout the body, caused by an excess burden of serum uric acid (sUA). The study estimates pharmacy and medical cost budgetary impacts of wider adoption
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da12c0910fd5b5ea75bee73e18db8521
https://pubmed.ncbi.nlm.nih.gov/27269247
Zobrazit plný text záznamu
9
Estimated economic benefits from low-frequency administration of atypical antipsychotics in treatment of schizophrenia: a decision model
Autor: Nicolas M Furiak, Robert W. Klein, Kent H. Summers, James C Gahn, S.B. Camper
Publikováno v: Annals of General Psychiatry, Vol 11, Iss 1, p 29 (2012)
Annals of General Psychiatry
The objective of this study was to quantify the direct medical resources used and the corresponding burden of disease in the treatment of patients with schizophrenia. Because low-frequency administration (LFA) of risperidone guarantees adherence duri
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::852cde41118403c8e9975c7d25aa3264
https://doi.org/10.1186/1744-859x-11-29
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje